The Technical Analyst
Select Language :
DigiPath, Inc. [DIGP]

Exchange: PNK Industry: Diagnostics & Research

DigiPath, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

DigiPath, Inc. is listed at the  Exchange

-2.53% $0.0320

America/New_York / 3 mai 2024 @ 15:34


DigiPath, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2.78 mill
EPS: -0.0100
P/E: -3.20
Earnings Date: N/A
SharesOutstanding: 87.10 mill
Avg Daily Volume: 0.0816 mill
RATING 2024-05-03
C+
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Sell
Return On Asset: Strong Buy
DE: Strong Sell
P/E: Neutral
Price To Book: Strong Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -3.20 | sector: PE -11.58
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE -3.20 | industry: PE -2.06
DISCOUNTED CASH FLOW VALUE
$-0.0241
(-175.26%) $-0.0560
Date: 2024-05-04
Expected Trading Range (DAY)

$ 0.0270 - 0.0370

( +/- 15.64%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2021-10-21 Douglass A Stone Buy 1 500 000 Common Stock
2021-07-01 Douglass A Stone Sell 1 000 000 Stock Option (Right to Buy)
2021-07-01 Denkin Todd Buy 1 500 000 Common Stock
2021-07-01 Denkin Todd Sell 0 Common Stock
2021-06-25 Hartmann Dennis Buy 125 000 Common Stock
INSIDER POWER
0.00
Last 90 transactions
Buy: 50 347 528 | Sell: 13 800 000

Forecast: 16:00 - $0.0320

Live Trading Signals (every 1 min)

Forecast 1: 15:44 - $0.0320
Forecast 2: 16:00 - $0.0320
Forecast 3: 16:00 - $0.0320
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.0320 (-2.53% )
Volume 0.0020 mill
Avg. Vol. 0.0816 mill
% of Avg. Vol 2.39 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for DigiPath, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for DigiPath, Inc.

RSI

Last 10 Buy & Sell Signals For DIGP

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            DigiPath, Inc.

DIGP

Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. The company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. In addition, its labs screen medicinal and recreational cannabis for potentially harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

Last 10 Buy Signals

Date Signal @
USTUSDMay 5 - 02:451.002
SOCKSUSDMay 5 - 02:3723 336
GALUSDMay 5 - 02:352.31
DIGGUSDMay 5 - 02:31719.06
KCSUSDMay 5 - 02:28$10.13
LMWRUSDMay 5 - 02:200.960
KWENTAUSDMay 5 - 02:2089.20
CAHUSDMay 5 - 02:1923.06
PEPECOINUSDMay 5 - 02:162.62
HBARUSDMay 5 - 02:18$0.110

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.